Daily Archives: March 26, 2021

QUEBEC CITY--(BUSINESS WIRE)--Devonian Health Group Inc. (Devonian or the Corporation) (TSXv: GSD), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, provides further details on previously announced results of Thykamine Phase 2 clinical trial for the treatment of mild-to-moderate atopic dermatitis (AD).

In this 4-week, phase 2, randomized, double-blind, multicentre, placebo-controlled study, adult patients with mild-to-moderate AD were randomized to receive Thykamine cream 0.05%, 0.10%, 0.25% or vehicle cream (placebo) twice daily. The primary efficacy endpoint was the Investigator Global Assessment (IGA) success rate defined as percentage of patients with an IGA score of 0 or 1 with greater than or equal to 2-grade reduction at week 4. Secondary endpoints included Body Surface Area (BSA) and Eczema Area and Severity Index (EASI). A total of 162 patients, spread over several sites in Canada, were recruited for this study.

IGA success rates at week 4 were 6.7% for placebo (vehicle cream), 19.0% for Thykamine cream 0.05% (p=0.053 vs placebo), 30.8% Thykamine cream 0.10% (p=0.014 vs placebo) and 12.1% for Thykamine cream 0.25% (p=0.461 vs placebo). Success rate over placebo of Thykamine cream 0.1% was not only reached at week 4 but also at week 3 (p = 0.04), resulting in a fast onset of the therapeutic effect. As such, Thykamine cream 0.10% has been retained for Phase 3 trials.

In addition, Thykamine achieved statistically significant differences, compared to placebo, in its key secondary efficacy endpoint, i.e. BSA.

Lastly, Thykamine was well-tolerated, as very few adverse events were reported.

"The efficacy of Thykamine obtained in this clinical trial was as expected and compared favourably to published results of other therapeutic products such as the phosphodiesterase inhibitors (PDE4)1,2 and calcineurin inhibitors,3 demonstrating that a Botanical Drug candidate can be as potent as a product derived from chemical synthesis." said Dr Andr P. Boulet, President and CEO of Devonian. "With the successful completion of this dose ranging study, we can now move into phase 3 clinical development in the adult patients. We are also planning a clinical trial within the pediatric patient population" added Dr Boulet.

Grant of Stock Options

In addition, the Company announces that the Board of Directors has approved the grant of 60,000 stock options (the "Options") to a member of the Board of Directors. These options are exercisable on the grant date, at a price of $ 0.20, for a period of 10 years.

About Atopic Dermatitis (AD)

AD, also known as eczema, is a type of inflammation of the skin. It results in itchy, red, swollen, and cracked skin that may lead to secondary infection. The condition typically starts in childhood with changing severity over the years. Although the cause of AD is unknown, it is believed to involve genetics, a compromised immune system and can be triggered by environmental factors. AD is the most common skin disease4 and its prevalence continues to increase worldwide. In the United States, the incidence has been reported to be 10-20% of children with new diagnoses at almost 11% per year5. The severity of AD can be categorized into three stages, mild, moderate, and severe. The mild and moderate forms constitute approximately 67% and 26% respectively of the AD childhood patient population. A similar distribution has been reported in the adult patient population (71% and 26% respectively) 6,7. There is currently an enormous unmet need for new, effective, and well-tolerated treatment options in AD8.

About Thykamine

Thykamine, the first pharmaceutical product issued from Devonians SUPREX platform, is a highly innovative product for the prevention and treatment of health conditions related to inflammation and oxidative stress including ulcerative colitis, atopic dermatitis, psoriasis, rheumatoid arthritis, and other autoimmune disorders. The anti-inflammatory, anti-oxidative and immunomodulatory properties of Thykamine have been demonstrated by a considerable number of in vitro and in vivo studies as well as in a Phase IIa clinical study in patients with mild-to-moderate distal ulcerative colitis. Thykamine is currently under development as treatment for ulcerative colitis and atopic dermatitis. Both Thykamine and SUPREX platform are protected by several patents in North America, Europe and Asia.

About Devonian

Devonian Health Group Inc. is a late-stage botanical pharmaceutical corporation with novel therapeutic approaches to targeting unmet medical needs. Devonian's core strategy is to develop prescription botanical drugs from plant materials and algae for the treatment of inflammatory-autoimmune diseases including but not limited to ulcerative colitis and atopic dermatitis. Based on a foundation of over 15 years of research, Devonians focus is further supported by a US-FDA set of regulatory guidelines favouring a more efficient drug development pathway for prescription botanical drug products over those of traditional prescription medicines. Devonian is also involved in the development of high-value cosmeceutical products leveraging the same proprietary approach employed with their pharmaceutical offerings. Devonian Health Group Inc. was incorporated in 2015 and is headquartered in Qubec, Canada where it owns a state-of-the art extraction facility with full traceability from the seed to the pill. Acquired in 2018, Altius Healthcare Inc., its commercialization partner, brings opportunities for further diversification and growth potential. Devonian is traded publicly on the TSXV Exchange (TSXv:GSD).

For more information, visit http://www.groupedevonian.com

References

Forward Looking Statements

This press release contains forward-looking statements about Devonians objectives, strategies and businesses that involve risks and uncertainties. These statements are forward-looking because they are based on our current expectations about the markets we operate in and on various estimates and assumptions. Actual events or results may differ materially from those anticipated in these forward-looking statements if known or unknown risks affect our business, or if our estimates or assumptions turn out to be inaccurate. Such risks and assumptions include, but are not limited to, Devonians ability to develop, manufacture, and successfully commercialize value-added pharmaceutical and cosmeceutical products, the availability of funds and resources to pursue R&D projects, the successful and timely completion of clinical studies, the ability of Devonian to take advantage of business opportunities in the pharmaceutical and cosmeceutical industries, uncertainties related to the regulatory process and general changes in economic conditions. You will find a more detailed assessment of the risks that could cause actual events or results to materially differ from our current expectations in Devonians prospectus dated April 21st, 2017 under the heading Risk Factors related to Devonians business. As a result, we cannot guarantee that any forward-looking statement will materialize. We assume no obligation to update any forward-looking statement even if new information becomes available, as a result of future events or for any other reason, unless required by applicable securities laws and regulations.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Read the original post:
Devonian Health Group Provides More Details on Previously Announced Positive Topline Results From Phase 2 Clinical Trial of Thykamine in Adult...

Your skin, being your bodys largest organ, can throw a lot at you from acne and wrinkles to eczema and dullness. In your journey to control your complexion you may have run into a common problem: being overwhelmed by the sheer number of products out there. And many of them make some big claims.

You always have your board-certified dermatologist to turn to. And frankly, these true experts should absolutely be your go-to for all things skin care, especially if youre dramatically changing your routine or have developed a new skin condition. All the same, you may find yourself needing additional support, tips, and inspiration. Thats where bloggers and influencers come in.

RELATED:Dermatologists Share 7 Tips for Soothing Dry Skin

These skin-care gurus palpable love for product tries, self-experiments with procedures like microneedling, and honesty about problems like acne will help you make decisions, figure out whats working for you (or not), and set you on the right path toward solving your skin issues.

In other words: They try it all so you dont have to.

The people on this list have a wholistic, compassionate, and candid approach to skin care thats easy to get behind. Heres who to follow:

Read this article:
The 7 Best Bloggers to Follow for Healthy-Skin Tips - Everyday Health

Atopic Eczema Treatment Marketreport incorporates a review, which clarifies esteem chain structure, modern viewpoint, provincial examination, applications, market size, offer, and conjecture. The Coronavirus (COVID-19) flare-up affecting the development of the market all around the world. The quickly changing business sector situation and starting and future appraisal of the effect are canvassed in the exploration report. The Atopic Eczema Treatment market gives a general examination of the market dependent on types, applications, local investigation, and the gauge time frame from 2021 to 2027.

The reports likewise remember speculation openings and plausible dangers for the market dependent on a canny investigation. This report centers around the Atopic Eczema Treatment Market patterns, future estimates, development openings, key end-client ventures, and market-driving players. The targets of the investigation are to introduce the key advancements of the market over the globe. The report presents a 360-degree review and SWOT investigation of the serious scene of the enterprises.

Request Sample For More Information @https://www.stratagemmarketinsights.com/sample/535

Development policy and plans are discussed as well asAtopic Eczema Treatment Market is split by article compose of production cost, deal income, request, and supply technique. The addition based on end client with utilization, investigation of past and future prospects of theAtopic Eczema Treatment piece of the overall industry, and the CAGR structure. Geographical provincial information will help you in focusing on all the best-performing locales.

A key factor driving the growth of the globalAtopic Eczema Treatmentmarket is the new product launches by regional and universal players as well. Manufacturers are adopting innovative strategies to increase the market share of their products. The success of new product launches is expected to accelerate players for business growth.

Top Key players: Leo Pharma, Velite Pharmaceutical, Pfizer, Anacor Pharmaceutical, Regeneron Pharmaceuticals, Sanofi

Product Type Coverage (Market Size & Forecast, Major Company of Product Type, etc.):

Type 1, Type 2,Type 3,Type 4, etc.

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile, etc.):

Application 1,Application 2,Application 3,Application 4, etc.

Key Region Coverage: Production, Demand & Forecast by Countries, etc.

Request A Discount On The Report @https://www.stratagemmarketinsights.com/discount/535

This report provides a detailed historical analysis of the global market forAtopic Eczema Treatmentand provides extensive market forecasts from 2021-2027 by region/country and subsectors. The report additionally gives upstream crude material examination and downstream interest investigation alongside the key advancement patterns and deals channel examination.

Major chapters covered in Aerospace Auxiliary Power Unit (APU) Market Research are:

NOTE: Our reports include the analysis of the impact of COVID-19 on this industry. Our new sample is updated which corresponds to a new report showing the impact of Covid-19 on Industry trends.

About Us:

Stratagem Market Insights is a management consulting organization providing market intelligence and consulting services worldwide. We bring the expertise of consultants with a cumulative industry experience of more than 70 years. The firm has been providing quantified B2B research and currently offers services to over 350+ customers worldwide. Our team includes analysts that leverage their years of experience and expertise to create accurate and error-free reports.

We offer an array of services including, syndicated research, advisory and consulting research process outsourcing, and content management. Our highly sought-after reports provide clients with key insights based on industry research, market size and forecast, market entry strategies, competitive intelligence, pricing analysis, consumer insights, procurement intelligence, and next-generation technologies.

Contact Us:

Mr. ShahStratagem Market InsightsTel: USA +1-415-871-0703JAPAN +81-50-5539-1737UK +44-203-289-4040Email:sales@stratagemmarketinsights.com

SD

Read more:
Atopic Eczema Treatment Market to have a Major Impact on the Market During 2021-2027 | Leo Pharma, Velite Pharmaceutical, Pfizer - The Courier

TORONTO--(BUSINESS WIRE)--Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (Heritage or the Company), is pleased to announce that, through a phased approach in 2021, the Company will be launching several new medical products formulated with the patented VESIsorb delivery system technology in the U.S. through its subsidiary Opticann, including ArthroCBD softgel capsules as well as topical cannabinoid applications that have been formulated to address some of the most pressing consumer health concerns, such as eczema, psoriasis, and local pain.

The first product, launching by April 19, 2021 on eCommerce channels is ArthroCBD, a 25 mg CBD and 6 mg beta-caryophyllene (BCP) softgel capsule formulated with VESIsorb for optimized absorption, bioavailability, and rapid onset of action. In addition, CBD topical applications formulated with VESIsorb for optimized dermal penetration and permeation are in the final stages of product development with a planned launch in the summer on opticann.com as well as at leading retailers in the food, drug, and mass channel of distribution. Opticanns CBD/CBDA sublingual filmstrip which is already planned for launch in Canada and Australia, will also be launched through the eCommerce effort later this year.

To support this effort, Opticann will present its products and brands at the National Association of Chain Drug Stores (NACDS) annual meeting in late April, with the expectation to be listed for launch at major U.S. retailers.

We continue to innovate and expand our clinically proven cannabinoid product offerings as we launch our initial suite of products formulated with the VESIsorb drug delivery system technology, commented Umar Syed, Heritages President, Medical Division. With our products, we aim to reach the broader healthcare market that includes sophisticated consumers and healthcare professionals who are seeking highly effective products that have substantial safety and efficacy data to support their utility for medical applications.

VESIsorb is a leading, innovative delivery system technology for dramatically improving the stability, absorption, and bioavailability of natural ingredients like cannabinoids, and is backed by a robust body of supporting scientific evidence spanning several decades. Most recently, the peer reviewed journal, Molecules, published the results of a double-blind, cross-over study (Molecules 2019,24(16), 2967) comparing the pharmacokinetic performance of a CBD extract formulated with VESIsorb to that of the same CBD extract formulated with industry standard (MCT) oil. Overall, the VESIsorb formulation showed statistically significant improvements for all measured parameters, including much higher total absorption (a 440% increase in maximum plasma CBD concentration (Cmax), and a 285% increase in total CBD exposure over 8 hours [area under the curve (AUC)]) and the time to reach the peak concentration 300% faster than the standard formulation (1 hour for VESIsorb versus 3 hours for the standard to reach Tmax).

About Heritage Cannabis Holdings Corp.

Heritage is a cannabinoid company focused on the production and sale of medical and recreational hemp-based and cannabis-based products and services. In Canada, Heritage operates through its subsidiaries Voyage Cannabis Corp. and CannaCure Corp., both regulated under the Cannabis Act Regulations. Working under these subsidiaries and the Purefarma, Pura Vida, Premium 5, RAD and feelgood. brands, Heritage focuses on extraction and the creation of derivative products for recreational consumers, as well as the formulation of cannabis based medical solutions. In the U.S., Heritage operates under Opticann Inc., a Colorado based oral and topical cannabinoid company with the rights to exclusively sell CBD and CBG products made with the patented VESIsorb drug delivery system for optimized absorption and stability. As the parent company, Heritage is focused on providing the resources for its subsidiaries to advance their products or services to compete both domestically and internationally.

ON BEHALF OF THE BOARD OF DIRECTORS OF HERITAGE CANNABIS HOLDINGS CORP.

Clint Sharples

Clint SharplesCEO

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

Read the original post:
Heritage Cannabis Announces the Upcoming Launch of CBD Product Applications Utilizing the Patented VESIsorb Delivery System Technology in the United...

The global dermatology diagnostic devices and therapeutics market is driven by rising number of patients suffering from skin allergies, fungal infections, and skin cancer owing to pollution and changes in the environment. In 2013, a study conducted on clinical dermatology found that 25% population was suffering from skin diseases. Among them, 15% consulted general physician which shows growing awareness among these patients for treatment of skin disease. This has boosted the demand for advanced treatments and drugs. As a part of this, key players have made investments in research and development (R&Ds) of advanced drugs.

For instance, recently, in March 2017, The US Food and Drug Administration (FDA) approved Dupixent (dupilumab) injection to treat moderate-to-severe eczema found in adults. Earlier, there were very few options to treat this disease. This is a product of one of the player operating in the market Sanofi and Regeneron Pharmaceuticals, Inc. Sanofi Genzyme, which is the business unit of Sanofi and Regeneron, will hold the market for the drug in the US. Dupixent is the first biologic medicine approved by FDA for treatment of atopic dermatitis (AD) eczema. This drug will be applicable when the disease cannot be controlled with topical prescription therapies or in the conditions where therapies are not advisable.

Get Brochure of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=1838

Dupixent is monoclonal antibody mainly designed for signaling two overactive proteins IL-4 and IL-13 which are majorly responsible for inflammation in an AD. It comes in the form of a pre-filled syringe which can be administrated by patients after the initial dose, it can be injected for every alternate week. Use of topical corticosteroids is not mandatory for injecting Dupixent. However, the drug is not suitable for patients who have dupilumab allergies or other ingredients present in the drug.

Currently, this drug is available in the US market. The launch of the drug is beneficial for the market to gather revenue substantially.

Global Dermatology Diagnostic Devices and Therapeutics Market: Overview

The global dermatology diagnostic devices and therapeutics market is gaining momentum due to the high prevalence of skin diseases and disorders. The trajectory of the global market will be decided by increasing pool of geriatrics, patent expirations in the offing, and the prevalence of chronic ailments. The research report points out that supportive governmental initiatives and increasing activities to raise awareness about dangerous skin disorders are expected to work in favor of the global market.

Global Dermatology Diagnostic Devices and Therapeutics Market: Drivers and Trends

The growing number of geriatrics is the key growth driver for the global dermatology diagnostic devices and therapeutics market. Aging skin is more prone to various types of skin cancer, invasive melanoma, and other diseases and disorders. Thus, increasing number of aged people have augmented the demand for dermatology diagnostic devices and therapeutics for diagnosing and treating the various conditions.

Buy this Premium Report @ https://www.tmrresearch.com/checkout?rep_id=1838&ltype=S

Rising pollution, changing lifestyles, and increasing usage of cosmetics has also resulted in high prevalence of acne and psoriasis, which in turn has had a positive influence on the global market. Furthermore, the increasing expenditure on healthcare and the introduction of new and improved dermatology diagnostics and devices and therapeutics have led to the growth of the overall market.

Global Dermatology Diagnostic Devices and Therapeutics Market: Market Potential

Several players are trying to incorporate technology used for developing diagnostic devices into smartphones and tablets to improve the rate of diagnostics. For instance, Agfa HealthCare launched its web-enabled mobile image management technology known as ICIS, which it plans to integrate into iPhones, iPads, and other mobile digital devices. Offering healthcare through smartphones is an important step in the way of medical devices are poised to evolve for the future. This is expected to provide the patient, caregivers, and physicians a chance to capture images at any point and from any location and publishing them on safely guarded EHRs.

Such initiatives are aimed towards improving diagnostics, patient engagement, and making healthcare even more reachable. Players in the global dermatology diagnostic devices and therapeutics market are expected to focus on making healthcare easy and accessible to win bigger user bases in the near future.

Global Dermatology Diagnostic Devices and Therapeutics Market: Regional Outlook

In terms of geography, the global dermatology diagnostic devices and therapeutics market is segmented into the Middle East and North Africa, Latin America, Asia Pacific, Europe, North America, and Rest of the World. Of these, North America is expected to dominate the global market due to a higher level of awareness about skin disorders and diseases in the region. The dominance of this region will be boosted by the excellent access to healthcare and supportive reimbursement policies. The well-organized healthcare sector is also projected favor the regional markets growth in the near future.

Europe is expected to follow North Americas lead in the coming years, while Asia Pacific will be seen as an important emerging market. The huge pool of geriatrics in Asia Pacific and the ever-increasing unmet medical needs in the developing countries of the region will also make a significant contribution to the soaring revenue of the overall market.

Key Players Mentioned in the Report are:

Some of the key players operating in the global dermatology diagnostics devices and therapeutics market are Valeant Pharmaceuticals International, Inc., Agfa-Gevaert N.V., Astellas Pharma, Inc., Cutera, Inc., Novartis International AG, Galderma S.A., Dino-Lite Europe/IDCP B.V., Genentech, LEO Pharma A/S, Michelson Diagnostics Ltd., and others.

Get Table of Content of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=1838

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in todays supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:

Rohit Bhisey

TMR Research,

3739 Balboa St # 1097,

San Francisco, CA 94121

United States

Tel: +1-415-520-1050

Visit Site: https://www.tmrresearch.com/

Visit link:
Dermatology Diagnostic Devices and Therapeutics Market | Existing and Future Insights in Growth - BioSpace

Hyaluronic acid is a sugar that occurs naturally in the body, including the skin, eyes, and joints. The primary function of hyaluronic acid is to provide moisture to these areas of the body.

Hyaluronic acid plays a crucial role in skin moisture. As people age, the moisture in their skin decreases, so some people choose to take supplemental hyaluronic acid.

This could be in the form of oral supplements, topical creams, serums, or even injections.

This article provides 11 evidence-backed benefits of using hyaluronic acid for the face and body. It explains how often a person can use hyaluronic acid and discusses types and side effects.

Learn more about hyaluronic acid here.

Many people use hyaluronic acid to hydrate their skin. People can take hyaluronic acid as a supplement, or they can apply it topically as a cream.

Hyaluronic acid can increase skin moisture and improve the quality of life for those with dry skin.

One 2014 study involved female participants applying topical hyaluronic acid as a lotion, serum, and cream. The study results demonstrated an increase of skin hydration of up to 96% after 8 weeks of use across the different types.

Learn about some other ways to keep skin healthy here.

Hyaluronic acid helps the skin maintain moisture and helps the tissue regeneration process involved in healing wounds.

One 2016 study suggested that applying hyaluronic acid to the skin to heal wounds can help relieve inflammation and regulate tissue repair.

Learn more about how wounds heal here.

When a person experiences changes in their skin, it can have an adverse psychosocial impact. This can occur during the aging process.

An older study found that hyaluronic acid can help reduce the roughness of a persons skin and increase skin elasticity.

Learn how to tighten loose skin here.

Around 50% of the bodys total hyaluronic acid is present in the skin. Changes in this amount, possibly due to UV exposure, can lead to the formation of wrinkles.

Hyaluronic acid can significantly decrease the depth of wrinkles and enhance skin firmness and elasticity.

One 2014 study involved women applying hyaluronic acid topically, twice daily, for 8 weeks.

The study reported up to a 40% decrease in the depth of wrinkles and an up to 55% increase in skin firmness and elasticity compared with participants who did not apply the acid.

Learn more about treating wrinkles here.

The eyes contain high concentrations of hyaluronic acid.

Therefore, eye drops containing hyaluronic acid can help to treat symptoms of dry eyes.

A 2019 study found that taking a combination of oral and topical hyaluronic acid eased symptoms of dry eye in participants.

Learn what causes dry eyes at night.

Vaginal dryness often affects females following menopause. It can affect a persons quality of life.

One 2016 study found that a combination of hyaluronic acid cream and an estrogen cream helped to alleviate symptoms of vaginal dryness.

Researchers also noted that hyaluronic acid was the more effective of the two. So people who cannot use hormonal treatment, such as estrogen cream, could use hyaluronic acid alone to help ease symptoms.

Learn about the different causes of vaginal dryness here.

How often a person can use hyaluronic acid will depend on the type.

Typically, a person can use skincare products that contain hyaluronic acid twice a day, but it is essential to read the instructions as products will vary.

Hyaluronic acid is available in a variety of different forms.

Hyaluronic acid tablets have shown efficacy for treating several issues, including:

People should speak to their doctor or another healthcare professional before using any form of supplements, as they may interact with other medications.

Topical hyaluronic acid can come in the following forms:

Hyaluronic acid can help increase moisture levels in the skin and reduce signs of aging.

Because the body produces hyaluronic acid naturally, the chances of a person having an allergic reaction are low.

Therefore, hyaluronic acid in injection form can have a range of uses. It can have medical and cosmetic purposes.

One cosmetic purpose for hyaluronic acid is fillers, including facial and lip fillers. A dermatologist injects hyaluronic acid into the lips to give them a plumper appearance.

Learn about the differences between Botox and dermal fillers here.

People using hyaluronic acid regularly generally report very few side effects. This is probably because the body produces hyaluronic acid naturally, which means there is little risk of allergic reactions.

One 2012 study involved participants taking oral hyaluronic acid for 12 months. They reported zero side effects.

An older article noted that injectable hyaluronic acid could cause adverse effects. However, these effects tend to be due to the injection itself rather than the hyaluronic acid. Adverse effects may include:

People receiving an injection of hyaluronic acid should talk with their healthcare provider if they plan on becoming pregnant or are breastfeeding.

There is currently not enough evidence to indicate the impact on a fetus or newborn.

Learn more about allergies and rashes here.

People may be aware of the benefits of hyaluronic acid as an ingredient in skincare but may not be aware of its versatility.

Using hyaluronic acid supplements or topical products can help people maintain a youthful appearance and tackle many signs of aging. However, it can also help treat some medical conditions, such as vaginal dryness or joint pain.

People should consult a healthcare professional before taking supplements. They should make sure that any provider of injectable hyaluronic acid has registered with the appropriate governing bodies.

More here:
11 benefits of hyaluronic acid for the face and body - Medical News Today

A good body wash can really make or break your shower experience. Shopping for one may seem like one of the simpler beauty choices, but there are a lot of factors to consider when picking a body cleanser that's right for you. You'll want to take into account the smell, the price point, whether you need a formula gentle enough for sensitive skin, and if it has specific active skin-care ingredients like niacinamide for extra hydration or the acne-fighting salicylic acid.

Still, there are hundreds of options out there to choose from, so narrowing it down can be a feat. That's why we curated this list of a few dozen body washes that stand out above the rest. Some feature scents so heavenly that one lather will make you feel like you're sitting beachside on a tropical vacation, while others get the job done without any added fragrance. There are also the cleansers specially made to treat issues like acne and eczema or multitasking products that be used on the hair, face, and body.

If you're looking for the best body wash to suit your needs whatever they may be you can start by checking out our curated guide of favorites ahead.

Read more here:
22 Body Washes That'll Transform Your Shower Experience For the Better - POPSUGAR

Get Sample Report

Eczema Skin-Care Products Market research report is the new statistical data source added by A2Z Market Research.

Eczema Skin-Care Products Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing top players and the upcoming competitors. Business strategies of the key players and the new entering market industries are studied in detail. Well explained SWOT analysis, revenue share and contact information are shared in this report analysis.

Eczema Skin-Care Products Market is growing at a High CAGR during the forecast period 2021-2027. The increasing interest of the individuals in this industry is that the major reason for the expansion of this market.

Get the PDF Sample Copy (Including FULL TOC, Graphs and Tables) of this Report @:https://www.a2zmarketresearch.com/sample?reportId=418290

Note In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

Top Key Players Profiled in this report are: Aveeno, CeraVe, La Roche-Posay, Vanicream, Aveeno, First Aid Beauty, Neutrogena, Cetaphil, Dove, All Mighty Pacs, TaoTronics, Bestek and others.

The key questions answered in this report:

Various factors are responsible for the markets growth trajectory, which are studied at length in the report. In addition, the report lists down the restraints that are posing threat to the global Eczema Skin-Care Products market. It also gauges the bargaining power of suppliers and buyers, threat from new entrants and product substitute, and the degree of competition prevailing in the market. The influence of the latest government guidelines is also analyzed in detail in the report. It studies the Eczema Skin-Care Products markets trajectory between forecast periods.

Get up to 30% Discount on this Premium Report @:https://www.a2zmarketresearch.com/discount?reportId=418290

The cost analysis of the Global Eczema Skin-Care Products Market has been performed while keeping in view manufacturing expenses, labor cost, and raw materials and their market concentration rate, suppliers, and price trend. Other factors such as Supply chain, downstream buyers, and sourcing strategy have been assessed to provide a complete and in-depth view of the market. Buyers of the report will also be exposed to a study on market positioning with factors such as target client, brand strategy, and price strategy taken into consideration.

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Eczema Skin-Care Products market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Eczema Skin-Care Products market.

Table of Contents

Global Eczema Skin-Care Products Market Research Report 2021 2027

Chapter 1 Eczema Skin-Care Products Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Global Eczema Skin-Care Products Market Forecast

Buy Exclusive Report @:https://www.a2zmarketresearch.com/buy?reportId=418290

If you have any special requirements, please let us know and we will offer you the report as you want.

About A2Z Market Research:

The A2Z Market Research library provides syndication reports from market researchers around the world. Ready-to-buy syndication Market research studies will help you find the most relevant business intelligence.

Our Research Analyst Provides business insights and market research reports for large and small businesses.

The company helps clients build business policies and grow in that market area. A2Z Market Research is not only interested in industry reports dealing with telecommunications, healthcare, pharmaceuticals, financial services, energy, technology, real estate, logistics, F & B, media, etc. but also your company data, country profiles, trends, information and analysis on the sector of your interest.

Contact Us:

Roger Smith

1887 WHITNEY MESA DR HENDERSON, NV 89014

[emailprotected]

+1 775 237 4147

View original post here:
COVID 19 impact on Eczema Skin-Care Products market The Bisouv Network - The Bisouv Network

However, the practice can help even those with oilier skins with a targeted approach. Selectively slugging, as Dr. Marchbein puts it, means treating only the dehydrated or eczema-prone spots on your face or body. If you're acne-prone but want a similar effect, I would use a creamy moisturizer instead of petrolatum. Look for ingredients like ceramides, hyaluronic acid, glycerin, and dimethicone. And then you can spot treat with Vaseline where you're drier."

If you want to try out slugging, the process breakdown goes like this:

Between the dryness of winter and less regular exposure to fresh air in light of the pandemic, slugging has saved my dry skin. For the purpose of this review, I slugged in targeted dry spots on my face (i.e. my forehead, jawline, lips, and parts of my cheeks) and body for a little over a month. Since I do have combination, acne-prone skin, I avoided slugging all over my face and neck, though that is something you might consider if yours is on the dryer side or if you have mature skin.

I had reservations about putting petrolatum all over my face, to begin with, so this felt like a good way to dip my toes in. I slugged at night before bed, and the results you get in a month aren't something the camera would pick up necessarily, but you can definitely feel it when you wake up the next day. My skin was automatically holding onto moisture better, and I started realizing what dehydrated skin actually felt like. What I had always thought was tight or puffy morning skin was actually just dehydration, which thankfully, as we now know, is completely avoidable.

One of the fastest places I saw a difference on was my lips. If you have dry lips, try slugging them. Wet and moisturize on your lips and then seal it in with Vaseline. The skin on your lips is so much thinner, so you'll see a difference that day. As we head into warmer months, I'll still be slugging at night with a more targeted approach, readjusting accordingly as I pay more attention to my oil production and dehydrated areas.

Now that you've decided to try slugging, it's time to decide what product you should go for. Dr. Marchbein recommends CeraVe's Healing Ointment and La Roche-Posay Lipikar Daily Lotion, but Vaseline Pure Petrolatum works just fine. So does Aquaphor, but Dr. Marchbein warns us this last one does contain an ingredient called lanolin, so she warns against that option for those with lanolin sensitivities.

If you do go for the extra layer of hydration, the moisturizer you use beforehand is as important as the petrolatum you use to seal it. Check out some hydration recommendations below:

Dr. Jart+ Ceramidin Liquid

"This lotion is based in calming thermal spring water which is rich in selenium. The water has been shown to normalize the skin's microbiome and promote a healthy skin barrier. It also contains skin-softening shea butter, and soothing niacinamide", Zeichner shares with Teen Vogue.

Let us slide into your DMs. Sign up for the Teen Vogue daily email.

Want more from Teen Vogue? Check this out:

Link:
What Is Slugging? The Dermatologist-Approved TikTok Beauty Trend - Teen Vogue